Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 820.29 | 750.34 | 365.50 | ||
| High | 824.98 | 765.00 | 376.87 | ||
| Low | 816.29 | 747.37 | 363.36 | ||
| Latest | 820.96 | 755.43 | 370.61 | ||
| Change | +4.59 | +6.10 | +5.15 | ||
| % Change | +0.56% | +0.81% | +1.41% | ||
| Volume | 205,279 | 225,203 | 436,403 | ||
| 20-Day Average Volume | 343,442 | 761,726 | 1,198,674 | ||
| Previous Close | 816.37 | 749.33 | 365.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 818.77 | 770.11 | 387.02 | ||
| 20-Day Raw Stochastic | 57.78% | 37.68% | 34.30% | ||
| 20-Day Relative Strength | 46.77 | 52.78 | 40.79 | ||
| Weighted Alpha | +31.38 | +23.44 | +23.97 | ||
| Today's Opinion | 24% Buy | 72% Buy | 40% Sell | ||
| Previous Opinion | 8% Buy | 72% Buy | 40% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.78% since 01/14/26 | +0.39% since 01/14/26 | +2.21% since 01/14/26 | ||
| Low | 781.07 on 01/20/26 | 718.38 on 01/20/26 | 347.77 on 01/20/26 | ||
| High | 824.98 on 01/22/26 | 765.00 on 01/22/26 | 376.65 on 01/22/26 | ||
| 1-Month | |||||
| %Chg | -3.57% since 12/22/25 | -2.86% since 12/22/25 | -8.04% since 12/22/25 | ||
| Low | 770.67 on 01/12/26 | 718.38 on 01/20/26 | 347.77 on 01/20/26 | ||
| High | 858.80 on 12/24/25 | 821.11 on 01/09/26 | 427.05 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +0.91% since 10/22/25 | +29.47% since 10/22/25 | -19.35% since 10/22/25 | ||
| Low | 749.75 on 10/30/25 | 572.75 on 10/23/25 | 347.77 on 01/20/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 485.36 on 10/27/25 | ||
| 6-Month | |||||
| %Chg | +43.83% since 07/22/25 | +34.97% since 07/22/25 | +15.27% since 07/22/25 | ||
| Low | 566.42 on 07/23/25 | 541.00 on 10/13/25 | 322.30 on 07/23/25 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 495.55 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 50,519,420 | 78,753,832 | 48,282,376 | ||
| Shares Outstanding, K | 61,883 | 105,099 | 132,114 | ||
| Annual Sales | 2,252,040,000 | 14,202,000,000 | 2,248,240,000 | ||
| Annual Net Income | 833,040,000 | 4,412,600,000 | -278,160,000 | ||
| Last Quarter Sales | 1,151,340,000 | 3,754,300,000 | 1,249,030,000 | ||
| Last Quarter Net Income | 344,260,000 | 1,460,000,000 | 251,080,000 | ||
| 60-Month Beta | 0.38 | 0.39 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.18 on 10/30/25 | 11.83 on 10/28/25 | 2.90 on 10/30/25 | ||
| Latest Earnings Date | 02/26/26 | 01/30/26 | 02/12/26 | ||
| Most Recent Dividend | N/A | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 61.90 | 20.00 | 1,545.78 | ||